DEXCOM INC — Director's Dealing 2013

Jun 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-05-31

Reporting Person: DOUBLEDAY RICHARD (SVP, Worldwide Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-31	Common Stock	A	15000	$0.001	Acquired	106973	Direct

Footnotes

F1: The 15,000 restricted stock units were granted to Mr. Doubleday in connection with his recent promotion to Senior Vice President of Worldwide Sales. Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant in three equal annual installments. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.

F2: Included in this number are 90,667 unvested restricted stock units, 15,000 of which were granted on May 31, 2013 and shall vest through May 31, 2016, 50,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 17,083 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 8,584 of which were granted on March 8, 2011 and shall vest through March 8, 2014.